Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy

There is limited prognostic information to identify breast cancer patients who are at risk for late recurrences after adjuvant or neoadjuvant systemic therapy (AST). We evaluated the residual risk of recurrence and prognostic factors of 2838 patients with stage I–III breast cancer who were treated w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Natl Cancer Inst
Hauptverfasser: Brewster, Abenaa M., Hortobagyi, Gabriel N., Broglio, Kristine R., Kau, Shu-Wan, Santa-Maria, Cesar A., Arun, Banu, Buzdar, Aman U., Booser, Daniel J., Valero, Vincente, Bondy, Melissa, Esteva, Francisco J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2008
Schlagworte:
Brief Communications
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6592411/
https://ncbi.nlm.nih.gov/pubmed/18695137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djn233
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge